Compton Imaging of Ac-225 in Preclinical Phantoms With a 3D-positioning CZT Camera
<sup>225</sup>Ac-based radiopharmaceuticals for targeted alpha therapy (TAT) have shown positive outcomes in recent clinical trials and pre-clinical studies, and it has emerged as a promising solution for future cancer treatments. Small-animal in-vivo imaging is critical to better understand <sup>225</sup>Ac radiopharmaceuticals biokinetics and to accelerate evaluation and discovery of new <sup>225</sup>Ac radiopharmaceuticals. However, gamma-ray imaging of <sup>225</sup>Ac and its daughters is challenging due to the extremely low injected activities, the low branching ratios of the emitted <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>γ</mml:mi></mml:math> rays, and their broad range of energies. State-of-the-art scanners for single-photon emission computed tomography (SPECT) have sensitivity limitations when imaging such low activities, and imaging sessions of several hours are necessary, precluding in-vivo studies. We propose Compton imaging as an alternative to traditional SPECT imagers in order to enable a higher sensitivity and to decrease the minimum imageable activities of current systems. In this study, we explore a 3D-positioning cadmium zinc telluride (CZT) camera (M400, H3D) to achieve highly sensitive Compton imaging of <sup>225</sup>Ac daughters at both high-energy (440 keV from <sup>213</sup>Bi) and low-energy gamma rays (218 keV from <sup>221</sup>Fr). The Compton sensitivity of the imaging system with a source as close as possible from the detector (7 mm) were 1014(33) cps/MBq and 467(23) cps/MBq for <sup>213</sup>Bi and <sup>221</sup>Fr, respectively. We studied the response of the camera using <sup>225</sup>Ac point sources, including the demonstration of simultaneous imaging of <sup>213</sup>Bi and <sup>221</sup>Fr from multiple <sup>225</sup>Ac sources at sub- <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>μ</mml:mi> <mml:mtext>Ci</mml:mtext></mml:math> activity levels, ranging from 7.4 kBq to 25.9 kBq, in a 18-minute imaging session. Furthermore, we performed a mouse phantom experiment to demonstrate that we could form high-sensitive Compton images of <sup>213</sup>Bi and <sup>221</sup>Fr, concluding that we can image a mouse phantom with an activity of ~ 0.55 MBq in just 9 and 36 seconds for <sup>213</sup>Bi and <sup>221</sup>Fr, respectively, with a single detector head and in a single bed position. This is equivalent to imaging an activity of 3.7 kBq, a typical tumor uptake in mouse experiments with <sup>225</sup>Ac, in 23 minutes for <sup>213</sup>Bi and 90 minutes for <sup>221</sup>Fr with a small 5.7 cm × 5.7 cm area prototype. Increasing angular coverage would further increase sensitivity. Finally, we also compared Compton imaging with collimated imaging.
Authors
- Biswajit Das (ORCID: https://orcid.org/0000-0003-0746-5305)
- Michael Streicher (ORCID: https://orcid.org/0000-0003-4842-7807)
- J. Caravaca (ORCID: https://orcid.org/0000-0002-7971-852X)
- David Goodman (ORCID: https://orcid.org/0000-0001-8958-5970)
- Youngho Seo (ORCID: https://orcid.org/0000-0001-5908-6636)
- Baharak Mehrdel (ORCID: https://orcid.org/0000-0003-3329-794X)
Institutions
- Lawrence Berkeley National Laboratory (US)
- University of California, San Francisco (US)
- H3D (United States) (US)
- University of California, Berkeley (US)
Publication Details
- Journal
- IEEE Transactions on Radiation and Plasma Medical Sciences
- Published
- 2025-06-06
- DOI
- https://doi.org/10.1109/trpms.2025.3577212
- Citations
- 1
- Primary Topic
- Atomic and Subatomic Physics Research
- Type
- article
- Field-Weighted Citation Impact
- 1.25
Funders
- Fogarty International Center